Research Article
Evaluation of the Periodontal Status in Acromegalic Patients: A Comparative Study
Table 2
Characteristics for acromegaly patients and healthy SHIP-1 subjects.
| Variable | Acromegaly patients | Healthy SHIP-1 subjects | |
| | 32 | 128 | | Age (years) | 58 (48; 64) | 58 (48; 64) | 0.99 | Male gender | 50.0% | 50.0% | 1.00 | School education | | | | <10 years | 31.3% | 32.0% | | 10 years | 50.0% | 48.4% | | >10 years | 18.7% | 19.5% | 0.99 | Smoking status | | | | Never smoker | 40.6% | 39.1% | | Former smoker | 34.4% | 40.6% | | Current smoker | 25.0% | 20.3% | 0.77 | Diabetes mellitus** | 18.8% | 7.0% | 0.04 | Presence of metabolic syndrome | 34.4% | 36.7% | 0.81 | Body Mass Index (kg/m2) | 28.6 (25.4; 32.7) | 28.3 (25.1; 31.1) | 0.39 | Waist circumference (cm) | 92 (86; 104) | 95 (86; 102) | 0.96 | Systolic blood pressure (mmHg) | 127 (119; 138) | 134 (123; 143) | 0.16 | Diastolic blood pressure (mmHg) | 83 (75; 88) | 82 (75; 90) | 0.76 | Serum glucose (mmol/L)# | 5.4 (5.0; 6.8) | 5.2 (4.8; 5.8) | 0.26 | Serum triglycerides (mmol/L)# | 1.5 (1.0; 2.2) | 1.6 (1.1; 2.3) | 0.49 | Serum HDL-C (mmol/L)# | 1.3 (1.1; 1.6) | 1.1 (0.88; 1.4) | 0.004 | Serum LDL-C (mmol/L)# | 3.4 (3.0; 4.2) | 3.7 (3.0; 4.5) | 0.55 | Hormone replacement therapy | 18.8% | 0.0% | <0.001 | IGF-I (ng/mL) | 153 (107; 2012) | 138 (112; 173) | 0.19 | IGFBP-3 (ng/mL) | 4880 (3840; 5595) | 4085 (3580; 4625) | 0.004 | IGF-I/IGFBP-3 | 0.035 (0.028; 0.041) | 0.034 (0.029; 0.042) | 0.74 | Mean CAL (mm) | 2.28 (1.35; 3.67) | 2.19 (1.02; 3.39) | 0.43 | Mean PD (mm) | 2.30 (1.92; 2.78) | 2.10 (1.87; 2.58) | 0.42 | Number of missing teeth | 7 (2; 11) | 6 (2; 12) | 0.65 | Missing teeth ≥10 | 28.1% | 30.5% | 0.80 |
|
|
Data are presented as percentages or median (25% quantile; 75% quantile). IGF-I: insulin-like growth factor-1; : number; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; CAL: clinical attachment loss; PD: probing depth.
*Chi-square test (categorical data) or Mann-Whitney- test (continuous data).
**Self-reported physician’s diagnosis or antidiabetic treatment (ATC code A10).
#Nonfasting blood samples.
|